CaseVu
Precipio Announces Q3-2021 And Year-End Shareholder Update Call
Conference Call to be held on Monday, November 15th, 2021 at 5:00 PM EST NEW [...]
Nov
American Oncology Network Partners With Precipio To Bring HemeScreen® Into AON’s Laboratory
HemeScreen Assays will enable AON to deliver rapid patient diagnostics for hematologic malignancies through advanced [...]
Aug
Precipio Reschedules Q2-2021 Shareholder Update Call
Due to a schedule conflict, the call is moved to Thursday August 26th at 5:00PM [...]
Aug
Precipio Announces Q2-2021 And Year-End Shareholder Update Call
Conference Call to be held on Monday, August 23rd, 2021 at 5:00 PM EST NEW [...]
Aug
Precipio Announces Preliminary Unaudited Q2-2021 Revenues Of $2.3M
Increase of 65% YoY, and 29% from Q1-2021 due to strong Pathology Growth and HemeScreen [...]
Jul
Precipio Terminates Its Equity Line
NEW HAVEN, CT, (Jun 15th, 2021) – Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announces that as part [...]
Jun
Precipio Launches HemeScreen® Anemia Panel, A One-Of-Its-Kind Testing Tool
Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes [...]
Jun
Precipio Announces Q1-2021 And Year-End Shareholder Update Call
Conference Call to be held on Thursday, May 20th, 2021 at 5:00 PM EST NEW [...]
May
Precipio Launches New HemeScreen Panel For AML, With An Unparalleled 4-Hour Turnaround-Time
Physician Office Laboratory (POL) Customers will be able to immediately integrate this important test into [...]
May
Precipio Launches Its Rapid COVID-19 Antibody Test On Amazon Platform
Nirmidas’ test is available to POC healthcare providers with an Amazon business account NEW HAVEN, [...]
May